About Biocatalysis
Biocatalysis is a company based in Germany founded in 2002 was acquired by Cambrex in March 2010. Biocatalysis operates in a competitive market with competitors including Almac Group, Seqens, Asymchem, Aurobindo Pharma and Aptuit, among others.
- Headquarter Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biocatalysis
Detailed funding history for Biocatalysis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biocatalysis
Biocatalysis has secured backing from 1 investor. Prominent investors backing the company include Cambrex.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO of complex small molecule APIs, including highly potent APIs
|
Locked | Locked | Locked |
Investor details for Biocatalysis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocatalysis
Investment portfolio details for Biocatalysis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biocatalysis
Detailed financials for Biocatalysis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocatalysis Comparisons
Peer comparison for Biocatalysis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocatalysis
Biocatalysis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Seqens, Asymchem, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
Contract manufacturing services for small molecules and peptides are provided.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
Contract research and development services for small molecules are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
Detailed competitors of Biocatalysis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocatalysis
Complete news archive for Biocatalysis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocatalysis
Biocatalysis was founded in 2002.
Biocatalysis is headquartered in Germany.
Thomas Loewald is the current CEO of Biocatalysis.
Biocatalysis was founded in 2002 in Germany and operates as a contract development and manufacturing organization. Small molecule drugs and peptides are produced through biocatalytic processes for pharmaceutical clients. Services include process development, scale-up, and quality-controlled production. The company is based in Germany, serving the biotech and pharmaceutical sectors with specialized manufacturing capabilities.
Biocatalysis's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Biocatalysis has 1 investor. Key investors include Cambrex.